On Thursday, UnitedHealth (UNH) plunged 22%, or by about $131 a share.

It’s a big part of why the Dow Jones lost about 500 points that day, too.

All after the company missed earnings and cut guidance.  

In fact, its EPS of $7.20 missed by nine cents. Revenue of $109.58 billion, up 9.8% year over year, missed by $2.02 billion. The company also revised its 2025 adjusted earnings outlook to $26.00 to $26.50, down from $29.50 to $30.00 per share. 

Headlines are leading traders to the slaughter. If you want the tools to outsmart the herd and fund your financial goals, click here.

While we wouldn’t try to catch the falling knife just yet, keep an eye on a potential, near-term reversal. For one, the stock has again tanked to historical support dating back to early 2022. Each time the stock has become this oversold, and over-extended on RSI, MACD and Williams’ %R, it historically bounces back strong.

We just need to wait for it to hold support and show confirmation of trend change before we jump into the opportunity. In addition, we can argue that a great deal of negativity has been priced into the stock’s $131 decline.

Again, wait for UNH to bottom out before buying.

Sincerely,

Ian Cooper